Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TDP2 anticorps

GMP Grade TDP2 Reactivité: Humain WB Hôte: Souris Monoclonal 42c unconjugated
N° du produit ABIN2704362
  • Antigène Voir toutes TDP2 Anticorps
    TDP2 (tyrosyl-DNA phosphodiesterase 2 (TDP2))
    Reactivité
    • 52
    • 31
    • 8
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 52
    • 15
    Souris
    Clonalité
    • 54
    • 13
    Monoclonal
    Conjugué
    • 28
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp TDP2 est non-conjugé
    Application
    • 51
    • 30
    • 28
    • 25
    • 23
    • 13
    • 13
    • 11
    • 7
    • 6
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Attributs du produit
    EAPII (also called TTRAP, TDP2) originally was identified as an interacting partner of oncogene ETS1, a founding member of ets transcription factor, and the cytoplasmic domain of CD40, a member of the tumor necrosis factor (TNF) receptor family. EAPII significantly represses ETS1 transcriptional activity and the synergistic transactivation by ETS1 and AP-1 or by ETS1 and NFκB. EAPII/TTRAP also inhibits the transcriptional activation of NFB induced by CD40 or phorbol 12-myristate 13-acetate (PMA). Recently this protein was also proven to be the first 5'- tyrosyl-DNA phosphodiesterase. EAPII has been demonstrated to have promiscuous protein associations, broad responsiveness to various extracellular signals, and pleiotropic functions in the development of human diseases including cancer and neurodegenerative disease. Emerging data suggest that EAPII is a multi-functional protein: it repairs enzyme (topoisomerase)-mediated DNA damage by removing phosphotyrosine from DNA adducts, involves in multiple signal transduction pathways such as TNF-TNFR, TGFβ and MAPK, and responsive to immune defense including inflammatory response, viral infection and DNA toxins (chemo or radiation therapy). EAPII predominantly localizes to the nucleus, but based on pathological conditions it also localizes in both cytoplasm and nucleus.
    Purification
    Purified
    Pureté
    >95 %
    Classe de qualité
    GMP Grade
    Immunogène
    Recombinant full length protein
    Clone
    42c
    Isotype
    IgG2b kappa
    Top Product
    Discover our top product TDP2 Anticorps primaire
  • Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.5 mg/mL
    Buffer
    PBS pH 7.2, 0.1 % (w/v) BSA, 0.09 % (w/v) sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C
  • Antigène
    TDP2 (tyrosyl-DNA phosphodiesterase 2 (TDP2))
    Autre désignation
    EAPII (TDP2 Produits)
    Synonymes
    anticorps AD022, anticorps EAP2, anticorps EAPII, anticorps TTRAP, anticorps dJ30M3.3, anticorps hTDP2, anticorps ad022, anticorps eap2, anticorps ttrap, anticorps D13Ertd656e, anticorps Ttrap, anticorps tdp2, anticorps ttrapl, anticorps tyrosyl-DNA phosphodiesterase 2, anticorps tyrosyl-DNA phosphodiesterase 2 S homeolog, anticorps tyrosyl-DNA phosphodiesterase 2b, anticorps TDP2, anticorps tdp2.S, anticorps Tdp2, anticorps tdp2b
    Sujet
    EAPII (also called TTRAP, TDP2) originally was identified as an interacting partner of oncogene ETS1, a founding member of ets transcription factor, and the cytoplasmic domain of CD40, a member of the tumor necrosis factor (TNF) receptor family. EAPII significantly represses ETS1 transcriptional activity and the synergistic transactivation by ETS1 and AP-1 or by ETS1 and NFκB. EAPII/TTRAP also inhibits the transcriptional activation of NFB induced by CD40 or phorbol 12-myristate 13-acetate (PMA). Recently this protein was also proven to be the first 5'- tyrosyl-DNA phosphodiesterase. EAPII has been demonstrated to have promiscuous protein associations, broad responsiveness to various extracellular signals, and pleiotropic functions in the development of human diseases including cancer and neurodegenerative disease. Emerging data suggest that EAPII is a multi-functional protein: it repairs enzyme (topoisomerase)-mediated DNA damage by removing phosphotyrosine from DNA adducts, involves in multiple signal transduction pathways such as TNF-TNFR, TGFβ and MAPK, and responsive to immune defense including inflammatory response, viral infection and DNA toxins (chemo or radiation therapy). EAPII predominantly localizes to the nucleus, but based on pathological conditions it also localizes in both cytoplasm and nucleus.
    NCBI Accession
    NM_016614
    UniProt
    O95551
Vous êtes ici:
Support technique